Petco lifts margins, EBITDA with services and cost cuts despite sales decline and high leverage

Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) - quick read on what's happening inside

Headline:
The company is squeezing profitability through tighter cost control and services growth even as product sales and comparable sales decline modestly. Liquidity looks adequate but leverage remains high.

Key facts & statistics (from the August 2, 2025 10‑Q)
- Total net sales (Qtr): $1,488,529 thousand (Thirteen weeks ended August 2, 2025).
- Net sales change: down $35,226 thousand, (2.3%) vs prior-year quarter; comparable sales down (1.4%) for the quarter, (1.3%) YTD.
- Gross profit (Qtr): $585,319 thousand; gross margin 39.3% (vs 38.1% prior-year quarter).
- Operating income (Qtr): $43,022 thousand (vs $2,468 thousand prior-year quarter).
- Net income attributable to Class A and B‑1 stockholders (Qtr): $13,972 thousand (vs loss $(24,823) thousand prior-year quarter).
- EPS (Basic/Diluted, Qtr): $0.05 / $0.05 (vs $(0.09) prior-year quarter).
- Adjusted EBITDA (Qtr): $113,860 thousand (up from $83,523 thousand prior-year quarter); YTD Adjusted EBITDA $203,309 thousand (vs $159,167 thousand).
- Free Cash Flow (YTD 26 weeks): $9,922 thousand (Net cash from ops $70,438; CapEx $60,516).
- Cash and cash equivalents: $188,748 thousand (Balance Sheet); cash, cash equivalents and restricted cash at end of period (per cash flow): $189,732 thousand.
- Total assets: $5,153,282 thousand; Total liabilities: $4,014,179 thousand; Stockholders' equity: $1,139,103 thousand.
- Inventories (net): $608,506 thousand (down from $653,329 thousand at Feb 1, 2025).
- Accounts payable & book overdrafts: $423,269 thousand (down from $492,878 thousand).
- First Lien Term Loan outstanding principal: $1,595.3 million (net of discounts $1,584.4M); weighted average interest rate 7.9%.
- ABL Revolving availability: $495.2 million available (net of letters of credit and borrowing base reductions).
- Pet care centers: 1,388 (vs 1,420 prior-year).
- Equity-based comp (Qtr): $8,789 thousand (vs $11,914 thousand prior-year quarter).

What's changing inside the company
- Management is prioritizing margin and profitability over top-line growth: disciplined pricing, fewer promotions and tighter unit-cost management drove higher gross margin despite lower sales.
- Services (veterinary and in-store services) continue to gain momentum and are supporting higher gross profit and Adjusted EBITDA.
- Inventory reductions and lower payroll/consulting costs helped reduce SG&A as a percentage of sales (36.4% vs 37.9%).
- The company continues active interest-rate hedging (swaps/collars) - AOCI shows unrealized hedge losses but small and being reclassified to interest expense over time.

Positive aspects (income statement & cash flow)
- Operating income improved sharply: $43.0M vs $2.5M prior-year quarter - real operational leverage.
- Net income turned positive this quarter: $13.97M vs a loss prior year - EPS positive at $0.05.
- Adjusted EBITDA expanded materially (Qtr +36% yoy), showing better underlying operating performance.
- Gross margin improved to 39.3% (from 38.1%), reflecting better inventory and pricing execution.
- Operating cash flow is healthy at $70.4M YTD and the company produced positive Free Cash Flow ($9.9M) despite heavy CapEx.

Negative aspects / risks (income statement & balance sheet)
- Sales are declining: net sales down 2.3% (Qtr and YTD) and comparable sales negative - demand softness or mix shift remains a headwind.
- Leverage remains high: First Lien Term Loan ~ $1.595B; total liabilities $4.014B against equity $1.139B - interest burden remains significant (interest expense $33.3M Qtr; $66.8M YTD).
- Free Cash Flow is small ($9.9M YTD) - limited cushion if sales weaken further or interest costs rise.
- Store count has declined (1,388 vs 1,420), which pressures top-line growth potential from the physical footprint.
- Some earnings volatility from tax law changes (OBBBA) and deferred tax effects; hedging AOCI swings could move through P&L.
- Anti-dilutive potential shares: ~16.5M potential shares excluded from diluted share count YTD (can pressure future EPS if converted).

Operational and financial takeaways - straight to the point
- Management is executing a margin-first turnaround: better gross margin and lower SG&A % produced operating leverage even with lower sales.
- Services and veterinary execution are the growth/stability drivers; product categories (consumables, supplies) are softer.
- Liquidity is adequate for the next 12 months: cash ~$189M + ABL availability ~$495M = reported liquidity ~$683.9M, but high term‑loan debt and interest costs keep capital structure elevated.
- Watch: comparable sales trend, interest rates/ refinancing risk, and whether Free Cash Flow can improve beyond breakeven levels as the company invests in services and reduces cost.

Bottom line: Petco (NASDAQ: WOOF) is moving the business toward profitability - earnings, margins and Adjusted EBITDA are all improving - but top-line pressure, elevated leverage and modest Free Cash Flow leave execution and interest-rate exposure as the main risks to monitor.